Background
Multisystem inflammatory syndrome in children (MIS-C) is a rare condition associated with SARS-CoV-2 (the virus that causes COVID-19), that usually occurs 2-6 weeks after a child is infected with SARS-CoV-2. The child’s SARS-CoV-2 infection may be very mild or have no symptoms at all and may go unrecognized. MIS-C causes different internal and external body parts to become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal tract. MIS-C can be serious, even deadly, but most children who are diagnosed with this condition get better with medical care
Publication
Belay ED, Godfred Cato S, Rao AK, Abrams J, Wilson WW, Lim S, Newton-Cheh C, Melgar M, DeCuir J, Webb B, Marquez P, Su JR, Meng L, Grome HN, Schlaudecker E, Talaat K, Edwards K, Barnett E, Campbell AP, Broder KR, Bamrah Morris S. Multisystem Inflammatory Syndrome in Adults after SARS-CoV-2 infection and COVID-19 vaccination. Clin Infect Dis. 2021 Nov 28;cia963.
Inclusion Criteria
Age groups
- 5-11 years
MedDRA PTs:
- MIS-C
- MISC
- MIS
- MIS-V
- Multisystem inflammatory syndrome
- Multisystem inflammatory
- “Multisystem” + “inflammation”
- “Multisystem” + “inflammatory”
- “Kawasaki”
- KD
Exclusion Criteria
- Patients above 11 years and below 5 years
- Clinical Data and medical records,
- Race and Ethnicity,
- Days post vaccination,
- Reporter criteria
Time period for Reporting
11/1/2021- 3/31/2022